相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers
I. A. Ivens et al.
HAEMOPHILIA (2013)
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
Henrik Ostergaard et al.
BLOOD (2011)
Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment
Baisong Mei et al.
BLOOD (2010)
Considerations in the laboratory assessment of haemostasis
A. McCraw et al.
HAEMOPHILIA (2010)
Longer-acting factor VIII to overcome limitations in haemophilia management: the PEGylated liposomes formulation issue
G. Di Minno et al.
HAEMOPHILIA (2010)
Discrepancies between APTT results determined with different evaluation modes on automated coagulation analyzers
M. Milos et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2010)
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
J. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Emerging PEGylated drugs
Jung Seok Kang et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
Influence of source of phospholipids for APTT-based factor IX assays and potential consequences for the diagnosis of mild haemophilia B
C. Pouplard et al.
HAEMOPHILIA (2009)
Anti-cancer PEG-enzymes: 30 years old, but still a current approach
Gianfranco Pasut et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Comparison of optical and mechanical clot detection for routine coagulation testing in a large volume clinical laboratory
Bing Bai et al.
BLOOD COAGULATION & FIBRINOLYSIS (2008)
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Marilyn J. Manco-Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Detection of shortened activated partial thromboplastin times: An evaluation of different commercial reagents
Edwin ten Boekel et al.
THROMBOSIS RESEARCH (2007)
Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: A review
H Kourlas et al.
CLINICAL THERAPEUTICS (2006)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Discrepant factor VIII activity in a family with mild haemophilia A and (Arg)531(His) mutation using various FVIII assays and APTT reagents
JF Lucia et al.
HAEMOPHILIA (2005)
Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays
J Ingerslev et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Pegvisomant in the treatment of acromegaly
C Parkinson et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
The partial thromboplastin time: defining an era in coagulation
GC White
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
The use of fluorogenic substrates to monitor thrombin generation for the analysis of plasma and whole blood coagulation
MK Ramjee
ANALYTICAL BIOCHEMISTRY (2000)
分享论文
